This finding is consistent with a meta-analysis showing that the levels of IL-6 and IL-8 in cerebrospinal fluid were significantly increased in patients with MDD, whereas no significant difference was found in the KYN pathway metabolites [39]. This evidence concerns the gene IL6 and major depressive disorder.